financetom
Business
financetom
/
Business
/
V2X Wins $103 Million US Navy Contract for C-26 Aircraft Maintenance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
V2X Wins $103 Million US Navy Contract for C-26 Aircraft Maintenance
May 25, 2025 8:07 PM

10:25 AM EDT, 04/28/2025 (MT Newswires) -- V2X (VVX) said Monday it has won a $103 million contract from the US Navy for Contractor Logistics Support maintenance of C-26 aircraft.

Under the firm-fixed-price contract expected to start in June, V2X will continue providing full support, including engineering, maintenance and modifications, for eight C-26A/D aircraft across three international bases and one US site, the company said.

Price: 50.06, Change: +0.25, Percent Change: +0.50

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
KKR's Bid to Acquire Perpetual Business Segments Rejected
KKR's Bid to Acquire Perpetual Business Segments Rejected
Feb 24, 2025
04:19 AM EST, 02/24/2025 (MT Newswires) -- KKR's (KKR) bid to acquire segments of Perpetual has been rejected, the Australian asset management company said Monday. Perpetual was considering an offer from KKR for its corporate-trust and wealth-management businesses but said it is now terminating the talks in accordance with the recommendations of an independent expert. Perpetual and KKR have engaged...
Takeda Secures EMA Approval for Additional Injection Option for Hereditary Angioedema Drug
Takeda Secures EMA Approval for Additional Injection Option for Hereditary Angioedema Drug
Feb 24, 2025
04:26 AM EST, 02/24/2025 (MT Newswires) -- Takeda Pharmaceutical Co ( TAK ) said Monday that the European Medicines Agency has approved an additional subcutaneous administration option for hereditary angioedema drug TAKHZYRO, or lanadelumab. The drug now comes in a 2 mL pre-filled pen for adolescent and adult patients, the company said. Hereditary angioedema is a rare genetic disease that...
Update: Tesla, Stellantis, Volkswagen, BYD Under Probe by Italian Regulator Over EV Claims
Update: Tesla, Stellantis, Volkswagen, BYD Under Probe by Italian Regulator Over EV Claims
Feb 24, 2025
04:36 AM EST, 02/24/2025 (MT Newswires) -- (Updates with attribution to the Italian regulator's statement throughout the story.) Tesla (TSLA), Stellantis ( STLA ) , Volkswagen, and BYD are under investigation by Italy's antitrust agency for misleading buyers on battery capabilities of their electric vehicles, the Italian Competition Authority said Friday. The inquiries focus on potentially unfair commercial practices regarding...
Kremlin says it does not see any possibility to renew dialogue with Europe at the moment
Kremlin says it does not see any possibility to renew dialogue with Europe at the moment
Feb 24, 2025
MOSCOW, Feb 24 (Reuters) - Russia does not see any grounds to renew dialogue with Europe for now, Kremlin spokesman Dmitry Peskov said on Monday, hours after the EU agreed on a sixteenth package of sanctions against Russia over the conflict in Ukraine. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved